Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Romano, M.
Right arrow Articles by Davì, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romano, M.
Right arrow Articles by Davì, G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 24:1674-1678, 2001
© 2001 by the American Diabetes Association, Inc.


Pathophysiology/Complications
Original Article

Endothelial Perturbation in Children and Adolescents With Type 1 Diabetes

Association with markers of the inflammatory reaction

Mario Romano, MD1, Mariapina Pomilio, MD2, Sergio Vigneri, MD3, Angela Falco, MD4, Pierluigi Lelli Chiesa, MD5, Francesco Chiarelli, MD2 and Giovanni Davì, MD4

1 Department of Human Pathology, University of Messina, Messina
2 Department of Medicine and Aging, Division of Pediatrics, University of Chieti, Chieti
3 Department of Medicine, University of Palermo, Palermo
4 Department of Medicine and Aging, Division of Hematology, University of Chieti, Chieti
5 the Department of Medicine and Aging, Division of Pediatric Surgery, University of Chieti, Chieti, Italy

OBJECTIVE—The progression of diabetic angiopathy is, in most cases, unpredictable. The aim of this study was to investigate early events that could influence the development of diabetic angiopathy.

RESEARCH DESIGN AND METHODS—Circulating levels of von Willebrand factor (vWF) and tissue-plasminogen activator (tPA), defining endothelial perturbation, were measured in 40 young patients with type 1 diabetes. Patients were divided into two groups according to the duration of diabetes (group A, <1 year; group B, >1 year) and compared with a control group of age- and sex-matched healthy individuals. Prothrombin fragment 1 and 2 (F1+2), tumor necrosis factor-{alpha} (TNF-{alpha}), and C-reactive protein (CRP) levels were also determined as markers of a prothrombotic state and inflammatory response. A total of 16 of the 20 children in group A were re-examined after 12 months.

RESULTS—Compared with either normal subjects or patients in group B, children in group A showed increased levels of vWF, tPA, F1+2, TNF-{alpha}, and CRP. Significant direct correlations between TNF-{alpha} or CRP and either vWF, tPA, or F1+2 were observed. Endothelial perturbation was shown in 70% of group A and 20% of group B. After 1 year, 16 of the 20 patients in group A showed a significant reduction in vWF, tPA, F1+2, TNF-{alpha}, and CRP levels, whereas endothelial perturbation was reversed in 5 of these patients.

CONCLUSIONS—Endothelial perturbation represents an early and, in some cases, reversible event in the chronology of type 1 diabetes in children. A correlation might exist between the initial inflammatory reaction and the appearance of endothelial perturbation.

Abbreviations: CRP, C-reactive protein • ELISA, enzyme-linked immunosorbent assay • F1+2, prothrombin fragment 1 and 2 • ICA-IgG, anti-islet cell antibodies • IL-1ß, interleukin-1ß • IL-6, interleukin-6 • TNF-{alpha}, tumor necrosis factor-{alpha} • tPA, tissue-plasminogen activator • vWF, von Willebrand factor


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
M. F. Lopes-Virella, R. E. Carter, G. E. Gilbert, R. L. Klein, M. Jaffa, A. J. Jenkins, T. J. Lyons, W. T. Garvey, G. Virella, and and the DCCT/EDIC Cohort Study Group
Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications
Diabetes Care, October 1, 2008; 31(10): 2006 - 2012.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
O. Kwon, S.-M. Hong, T. A. Sutton, and C. J. Temm
Preservation of peritubular capillary endothelial integrity and increasing pericytes may be critical to recovery from postischemic acute kidney injury
Am J Physiol Renal Physiol, August 1, 2008; 295(2): F351 - F359.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J.-W. Xu, I. Morita, K. Ikeda, T. Miki, and Y. Yamori
C-Reactive Protein Suppresses Insulin Signaling in Endothelial Cells: Role of Spleen Tyrosine Kinase
Mol. Endocrinol., February 1, 2007; 21(2): 564 - 573.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
K. O. Schwab, J. Doerfer, W. Hecker, J. Grulich-Henn, D. Wiemann, O. Kordonouri, P. Beyer, R. W. Holl, and on behalf of the DPV Initiative of the German Work
Spectrum and Prevalence of Atherogenic Risk Factors in 27,358 Children, Adolescents, and Young Adults With Type 1 Diabetes: Cross-sectional data from the German diabetes documentation and quality management system (DPV)
Diabetes Care, February 1, 2006; 29(2): 218 - 225.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
F. Chiarelli, D. Di Marzio, F. Santilli, A. Mohn, A. Blasetti, F. Cipollone, A. Mezzetti, and A. Verrotti
Effects of Irbesartan on Intracellular Antioxidant Enzyme Expression and Activity in Adolescents and Young Adults With Early Diabetic Angiopathy
Diabetes Care, July 1, 2005; 28(7): 1690 - 1697.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
R. R. Dalton, W. H. Hoffman, G. G. Passmore, and S. L. A. Martin
Plasma C-Reactive Protein Levels in Severe Diabetic Ketoacidosis
Ann. Clin. Lab. Sci., October 1, 2003; 33(4): 435 - 442.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
M. R. Golomb, M. Rafay, D. Armstrong, P. Massicotte, R. Curtis, S. Hune, and G. A. deVeber
Intra-arterial Tissue Plasminogen Activator for Thrombosis Complicating Cerebral Angiography in a 17-Year-Old Girl
J Child Neurol, June 1, 2003; 18(6): 420 - 423.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.